Advertisement

Volcano agrees to give Crux Biomedical an extra 5 months to obtain 510(k) clearance for its retrieval device and land a $3 million milestone payment.

mergers and acquisitions illustration

Volcano (NSDQ:VOLC) agreed to give Crux Biomedical an extra 5 months to obtain FDA 510(k) clearance for a retrieval device, a milestone worth $3 million under the terms their merger agreement.

Under the amended agreement Crux has until Nov. 30, 2013, to win FDA clearance and satisfy the milestone. The previous deadline closed June 30.

Advertisement
Advertisement